Has Claudia Penalba, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,519 in general payments to Claudia Penalba, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Claudia Penalba, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Claudia Penalba, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Claudia Penalba, MD

Physical Medicine & Rehabilitation · Coral Gables, FLNPI 1093742504

Payments from drug & device makers

$1,519in general payments, 2019–2025

Across 14 payments — averaging $108.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$541
Abbott$283
Sunovion Pharmaceuticals Inc.$204
Neurocrine Biosciences, Inc.$165
Amarin Pharma, Inc.$120
AstraZeneca$107
plus $98 from 1 others

What the payments were for

Food & beverage$1,519100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	5	$541
Abbott	2	$283
Sunovion Pharmaceuticals Inc.	2	$204
Neurocrine Biosciences, Inc.	2	$165
Amarin Pharma, Inc.	1	$120
AstraZeneca	1	$107
Otsuka America Pharmaceutical, Inc.	1	$98

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,519 in reported general payments places this provider in the 80th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida →

Medicare billing

Part B allowed, 2024

$134,168

Medicare patients

478

Services billed

2,010

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tizanidine Hcl	17	$549
Gabapentin	26	$464
Tramadol Hcl	17	$152

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Coral Gables

Alan MillerFernandina Beach$784K
Anthony GiuffridaFort Lauderdale$443K
Paul WuOakland Park$311K
Marissa McCarthyTampa$239K
Ryan HafnerSarasota$200K
Cassandra ListJacksonville$154K
Benjamin WesterhausMangonia Park$100K
Michael YuClearwater$47K
Jose Medina SanchezTampa$30K
Anish SoniNaples$25K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →